适应新生儿阿片类药物戒断综合征的风险预测工具
Thomas J Reese1, Andrew D Wiese2, Ashley A Leech2
1Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.
Pediatrics
|March 2, 2025
概括
一个新的预测模型准确地识别出出生时患重症新生儿阿片类药物戒断综合征 (NOWS) 高风险的婴儿. 该工具有助于临床医生量身定制护理,并避免对暴露于阿片类药物的婴儿进行不必要的治疗.
科学领域:
- 新生儿护理 新生儿护理
- 药理学 药理学是指药理学的学科.
- 临床预测模型的临床预测模型.
背景情况:
- 新生儿阿片类药物戒断综合征 (NOWS) 管理指南建议对患有慢性阿片类药物暴露的婴儿进行长达7天的观察.
- 然而,并非所有暴露的婴儿都会患上NOWS,一些暴露不太明显的婴儿可能会出现严重的症状,需要药物治疗.
- 目前的查方法可能无法最佳地识别患有严重NOWS风险的婴儿.
研究的目的:
- 适应和验证一个预测模型,用于识别出生时可能患有严重NOWS的婴儿.
- 将预测模型的性能与现有的指南选标准进行比较.
主要方法:
- 进行了一项涉及33,991名分娩的预后研究.
- 严重的NOWS是由口服吗啡的管理定义的.
- 使用37个预测器开发了一种具有最少绝对收缩选择操作员方法的后勤回归模型.
- 使用决策曲线分析,将模型与慢性阿片类药物暴露查 (母亲OUD诊断或长效阿片类药物处方) 进行比较.
主要成果:
- 108名婴儿接受了NOWS的口服吗啡,1243名婴儿长期暴露于阿片类药物.
- 预测模型表现出高的区分能力,接收器操作曲线下的面积为0.959.
- 母亲诊断的阿片类药物使用障碍 (OUD) 是最强的预测因素 (调整后的几率比率,47.0).
- 与指导标准相比,决策曲线分析表明该模型在所有风险水平上的临床效用优越.
结论:
- 在出生时预测严重NOWS的风险可以提高临床决策.
- 该模型有助于量身定制非药物干预措施,并确定需要延长住院治疗的需要.
- 这种方法提供了一种比仅仅针对慢性阿片类药物暴露的查更精确的方法.
相关概念视频
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...


